Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Variants in Candidate Pharmacogenes with Response to Mercaptopurine and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Single-Center Experience from Croatia. | Oncol Ther | 2026 | 42168754 | PubTator, text mining | PubMed |
| Thiopurine Methyltransferase Levels and Azathioprine Outcomes in Thai Patients with Cutaneous Autoimmune Diseases. | Clin Cosmet Investig Dermatol | 2026 | 42094858 | PubTator, text mining | PubMed |
| Correction to "Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update". | Clin Pharmacol Ther | 2026 | 42050374 | PubTator, text mining | PubMed |
| Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology. | Clin Transl Sci | 2026 | 41995114 | PubTator, text mining | PubMed |
| CGE26-137: Association Between Genetic Ancestry and TPMT/NUDT15 Phenotypes in Patients From Brazil's Unified Health System (SUS). | J Natl Compr Canc Netw | 2026 | 41991022 | PubTator, text mining | PubMed |
| An integrated triple approach - TPMT phenotype, NUDT-15 genotype, and therapeutic drug monitoring of thiopurine metabolites for optimal clinical efficacy: a case series. | Per Med | 2026 | 41969197 | PubTator, text mining | PubMed |
| Comprehensive overview of the global pharmacogenetic and functional variability in NUDT15. | Hum Genomics | 2026 | 41935317 | PubTator, text mining | PubMed |
| Distribution of NUDT15*4 in Native American populations of the Brazilian Amazon and risk of intolerance to thiopurine drugs. | Front Pharmacol | 2026 | 41924139 | PubTator, text mining | PubMed |
| Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer. | Front Pharmacol | 2026 | 41847134 | PubTator, text mining | PubMed |
| Optimizing mercaptopurine therapy in indian pediatric ALL: The role of TPMT and NUDT15 genetic polymorphisms. | Cancer Treat Res Commun | 2026 | 41819030 | PubTator, text mining | PubMed |
| Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System. | Clin Transl Sci | 2026 | 41797503 | PubTator, text mining | PubMed |
| Supervised learning of protein variant effects across large-scale mutagenesis datasets. | Protein Sci | 2026 | 41795207 | PubTator, text mining | PubMed |
| PHARMACOGENETIC MARKERS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY. | Exp Oncol | 2026 | 41788072 | PubTator, text mining | PubMed |
| Acquired Immunodeficiency in Newborn Following Intrauterine Exposure to Thiopurines for Treatment of Inflammatory Bowel Disease. | ACG Case Rep J | 2026 | 41782673 | PubTator, text mining | PubMed |
| Population frequencies of thiopurine-related pharmacogenes in healthy individuals from Kosovo. | Hum Genome Var | 2026 | 41760597 | PubTator, text mining | PubMed |
| Pharmacogenomics of Antineoplastic Therapy in Children: Genetic Determinants of Toxicity and Efficacy. | Pharmaceutics | 2026 | 41754908 | PubTator, text mining | PubMed |
| Azathioprine-Associated Acute Pancreatitis Followed by a Probable Autoimmune Hepatitis Flare After Thiopurine Withdrawal: A Case Report. | Cureus | 2026 | 41732630 | PubTator, text mining | PubMed |
| Genetics of selenoproteins and selenoprotein metabolism - An overview of current concepts and emerging aspects. | Redox Biol | 2026 | 41719757 | PubTator, text mining | PubMed |
| Precision Pediatric Cancer Nanomedicine: Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs. | Int J Nanomedicine | 2026 | 41717314 | PubTator, text mining | PubMed |
| Translating IBD Genomics into Clinical Practice. | Dig Dis Sci | 2026 | 41689683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=2